clinical trial · NCT07487727
A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
Anemia Due to Chronic Kidney DiseaseAND017ESA
brief summary
This is a Phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in non-dialysis-dependent (NDD)-CKD patients compared with the active control, ESA treatment
started
Dec 3, 2025
primary completion
Dec 1, 2026
completion
Jul 1, 2027
last updated
Mar 27, 2026
official title
A Phase 3, Multi-center, Randomized, Open-Label, Active-Controlled, Efficacy and Safety Study of AND017 to Treat Anemia in Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol